virus vaccine infection medicines

Two new medicines may curb serious respiratory disease in infants

Reading now: 846
www.sciencemag.org

Jon CohenHalf a century of research has failed to thwart respiratory syncytial virus (RSV), which causes severe disease in the lower airways and lungs of some 3 million newborn children and kills more than 100,000 worldwide each year.

But now, two different approaches have had success. One gives a monoclonal antibody against RSV to the babies, whereas the other vaccinates their mothers against the virus, presumably leading to antibodies that protect their children.Although more studies are needed before either product comes to market, the results, both published today in The New England Journal of Medicine, have given a boost to a beleaguered field. “These two studies provide encouraging data that prevention of this common infection in.

Read more on sciencemag.org
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA